Objectif
The safety and efficacy of bone marrow transplantation using donors other than human leucocyte antigen (HLA) identical siblings was investigated. The results of analyses conducted are preliminary. Nonetheless a substantial proportion of leukemia patients were disease free, alive and well following transplantation of HLA incompatible bone marrow donated by family members.
Champ scientifique
Thème(s)
Data not availableAppel à propositions
Data not availableRégime de financement
CSC - Cost-sharing contractsCoordinateur
8701 MILWAUKEE
États-Unis